Identification of a promising PI3K inhibitor for the treatment of multiple myeloma through the structural optimization

Overview of attention for article published in Journal of Hematology & Oncology, January 2014

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 14,865 followers.

Novel agent BENC-511 inactivates PI3K & downstream AKT, mTOR, p70S6K, 4E-BP1; kills #myeloma cells in lab models (http://t.co/3OvOKNGb8a).

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.